Edwards Lifesciences (EW) Net Income towards Common Stockholders Growth (3y) (2012 - 2025)
Edwards Lifesciences (EW) Net Income towards Common Stockholders Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.32 Bn | 193.72 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.63 Bn | 126.16 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 119.98 Bn | 110.76 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.96 Bn | 73.42 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 52.42 Bn | 48.17 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.49 Bn | 32.55 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 17.54% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -59.23% |
| Sep 30, 2025 | -26.11% |
| Jun 30, 2025 | -26.22% |
| Mar 31, 2025 | -26.40% |
| Dec 31, 2024 | -51.06% |
| Sep 30, 2024 | 99.67% |
| Jun 30, 2024 | -87.31% |
| Mar 31, 2024 | -57.42% |
| Dec 31, 2023 | -50.92% |
| Sep 30, 2023 | -46.86% |
| Jun 30, 2023 | 34.70% |
| Mar 31, 2023 | 3.11% |
| Dec 31, 2022 | 12.45% |
| Sep 30, 2022 | 7.73% |
| Jun 30, 2022 | 18.81% |
| Mar 31, 2022 | 14.37% |
| Dec 31, 2021 | 263.17% |
| Sep 30, 2021 | 14.61% |
| Jun 30, 2021 | 20.08% |
| Mar 31, 2021 | 17.85% |